Latest inventory for YS: $230M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
LakeShore Biopharma Co (YS) currently reports a inventory of $230M as of March 2025. That compares with $210M in the prior-year period — up 11.0% year over year. Use the charts on this page to explore LakeShore Biopharma Co's inventory history and peer comparisons.
LakeShore Biopharma Co's inventory increased from $210M to $230M — a 11.0% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
LakeShore Biopharma Co reported $230M in inventory as of March 2025. That compares with $210M in the prior-year period — up 11.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.